ProQR has announced the completion of an in-depth strategic review designed to deliver on our commitment to advance RNA therapies for diseases with high unmet need. We are also sharing additional analyses of the sepofarsen Illuminate trial.
… her colleagues applied what she describes as “the amazing innovative retinal organoid model of ‘optic cups’.” She … and scientific chemistry”. Patricia insists that innovation can only be born in environments without …
… upcoming presentations at the Retinal Cell & Gene Therapy Innovation Summit, the annual meeting of the Association for … Gene and Cell Therapy (ASGCT). Retinal Cell & Gene Therapy Innovation Summit The conference is being held on Friday, … to our participation at the Retinal Cell & Gene Therapy Innovation Summit, the annual meeting of the Association for …
